Sionna Therapeutics

Sionna Therapeutics(SION)

WALTHAM, MA
Biotechnology
WebsiteLinkedInCareers Page

Focus: Small Molecule Targeting CF

Sionna Therapeutics is a life sciences company focused on Small Molecule Targeting CF.

UnknownRare Diseases
Funding Stage
PUBLIC
Open Jobs
4

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT07035990Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.
Phase 1
Phase 2
Clinical Trials (1)
NCT07108153Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta
Phase 2

Open Jobs (4)

VP, Corporate Communications

Unknown
Unknown
2w ago

Senior Director, Clinical Pharmacology Scientist

Unknown
Unknown
2w ago

Principal Scientist, CMC Drug Substance

Unknown
Unknown
2w ago

Director, Clinical Development MD

Unknown
Unknown
2w ago
Interview Prep Quick Facts
Founded: 2019
Portfolio: 2 clinical trials
SEC Filings: 1 available
Open Roles: 4 active jobs

Financials (FY2025)

R&D Spend
$57M
Net Income
-$62M
Cash
$38M
Source: SEC 10-K Filing